Company Overview
 
Board of Directors

Mark Skaletsky, Chairman of the Board
President and Chief Executive Officer, Fenway Pharmaceuticals
Newton, MA

M. James Barrett, Ph.D.
General Partner, New Enterprise Associates
Baltimore, MD

Charles A. Blixt, Esq.
General Counsel (Retired), Reynolds American
Winston-Salem, NC

Julia R. Brown
Advisor to the CEO, Amylin Pharmaceuticals
San Diego, CA

G. Steven Burrill
Chief Executive Officer,  Burrill & Company, LLC
San Francisco, CA

J. Donald deBethizy, Ph.D.
President and Chief Executive Officer, Targacept
Winston-Salem, NC

Errol B. De Souza, Ph.D.
President and Chief Executive Officer, Archemix Corporation
Cambridge, MA 

Alan W. Dunton, M.D.
Chief Executive Officer, Panacos Pharmaceuticals
Watertown, MA

John P. Richard
Managing Director, Georgia Venture Partners
Atlanta, GA

Ralph Snyderman, M.D.
Chancellor Emeritus, Duke University
James B. Duke Professor of Medicine, Duke University School of Medicine
Durham, NC

 

©2008 Targacept, Inc. Terms of Use Home Directions Contact Site Map  Go